Purchases and Sales Made in Q3 2022 in Chemo Centryx, Inc. (CCXI)
This table provides information about the institutional ownership of Chemo Centryx, Inc. (CCXI) during Q3 2022. The information is specifically focused on institutions that hold shares of ChemoCentryx, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 03, 2022
Q3 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-431K- 78.78% |
$9.56M - $22.3M
|
116K
$0
|
|
Nov 09, 2022
Q3 2022
|
Gw&K Investment Management, LLC
Boston, MA |
SELL
|
- |
-853K- 55.51% |
$18.9M - $44.2M
|
684K
$0
|
|
Nov 14, 2022
Q3 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-896K- 52.06% |
$19.9M - $46.4M
|
825K
$0
|
|
Nov 14, 2022
Q3 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-1.15M- 97.38% |
$25.5M - $59.5M
|
30.9K
$0
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.33M- 32.88% |
$29.5M - $68.9M
|
2.72M
$0
|
|
Nov 14, 2022
Q3 2022
|
Pictet Asset Management Sa
Geneva 73, V8 |
SELL
|
- |
-2.37M- 99.84% |
$52.5M - $123M
|
3.9K
$0
|